Certolizumab pegol for the treatment of psoriatic arthritis: 4-year outcomes from the RAPID-PsA trial

P. Goupille, P. J. Mease, R. Fleischmann, J. Wollenhaupt, A. Deodhar, D. Gladman, B. Hœpken, L. Peterson, D. Van Der Heijde

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Certolizumab pegol for the treatment of psoriatic arthritis: 4-year outcomes from the RAPID-PsA trial'. Together they form a unique fingerprint.